Orange Book product · Generic (ANDA)
CLOMIPHENE CITRATE
CLOMIPHENE CITRATE
At a glance
Nov 08, 2024
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Nov 08, 2024
1 yr 8 mo ago
Today
Pharmaceutical detail
Active ingredient
CLOMIPHENE CITRATE
Strength
50MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 216739
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of CLOMIPHENE CITRATE
- 1982SEROPHENEBrand (NDA)
NDA 018361 · EMD SERONO
- —CLOMIDBrand (NDA)
NDA 016131 · SANOFI AVENTIS US
- 2026CLOMIPHENE CITRATEGeneric (ANDA)
ANDA 220673 · ASCENT PHARMS INC
- 2025CLOMIPHENE CITRATEGeneric (ANDA)
ANDA 219781 · NOVITIUM PHARMA
- 2025CLOMIPHENE CITRATEGeneric (ANDA)
ANDA 219406 · ACCORD HLTHCARE
- 2024CLOMIPHENE CITRATEGeneric (ANDA)
ANDA 216545 · RUBICON RESEARCH
- 1999CLOMIPHENE CITRATEGeneric (ANDA)
ANDA 075528 · COSETTE
- 1988MILOPHENEGeneric (ANDA)
ANDA 072196 · GRANATA BIO CORP
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
